Rocket Pharmaceuticals Ownership 2024 | Who Owns Rocket Pharmaceuticals Now?
Institutional Ownership
8.97%
Insider Ownership
3.42%
Retail Ownership
87.61%
Institutional Holders
75.00
Rocket Pharmaceuticals Institutional Shareholders
Institutional Shareholders by % of Total Shares
| Name | % Total Shares | % Total Assets | Current Shares | Change Amount | Change % | Market Value | Date |
|---|---|---|---|---|---|---|---|
| RTW INVESTMENTS, LP | 18.87% | 5.90% | 17,687,772 | - | - | 380,817,731 | Jun 30, 2024 |
| WELLINGTON MANAGEMENT GROUP LLP | 9.77% | 0.04% | 9,155,720 | -379 | -0.00% | 197,122,652 | Jun 30, 2024 |
| BLACKROCK INC. | 6.61% | 0.00% | 6,192,627 | 262,717 | 4.43% | 133,327,260 | Jun 30, 2024 |
| VANGUARD GROUP INC | 6.20% | 0.00% | 5,808,550 | 437,665 | 8.15% | 125,058,083 | Jun 30, 2024 |
| WESTFIELD CAPITAL MANAGEMENT CO LP | 4.62% | 0.46% | 4,327,922 | 343,892 | 8.63% | 93,180,161 | Jun 30, 2024 |
| MAVERICK CAPITAL LTD | 4.19% | 1.60% | 3,928,312 | 40,000 | 1.03% | 84,576,557 | Jun 30, 2024 |
| PRICE T ROWE ASSOCIATES INC /MD/ | 3.38% | 0.01% | 3,169,448 | 226,288 | 7.69% | 68,239,000 | Jun 30, 2024 |
| JANUS HENDERSON GROUP PLC | 3.11% | 0.03% | 2,919,078 | 313,062 | 12.01% | 62,842,455 | Jun 30, 2024 |
| STATE STREET CORP | 2.97% | 0.00% | 2,779,866 | -1,413,211 | -33.70% | 59,850,515,000 | Jun 30, 2024 |
| FRANKLIN RESOURCES INC | 2.00% | 0.01% | 1,873,689 | 6,360 | 0.34% | 40,340,524 | Jun 30, 2024 |
| GEODE CAPITAL MANAGEMENT, LLC | 1.71% | 0.00% | 1,603,610 | 101,023 | 6.72% | 34,532,870 | Jun 30, 2024 |
| FRAZIER LIFE SCIENCES MANAGEMENT, L.P. | 1.67% | 1.57% | 1,561,230 | - | - | 33,613,282 | Jun 30, 2024 |
| BOXER CAPITAL, LLC | 1.56% | 1.66% | 1,466,051 | - | - | 31,564,078 | Jun 30, 2024 |
| PERCEPTIVE ADVISORS LLC | 1.33% | 0.64% | 1,246,597 | -554,471 | -30.79% | 26,839,233 | Jun 30, 2024 |
| BANK OF AMERICA CORP /DE/ | 1.32% | 0.00% | 1,238,044 | 219,556 | 21.56% | 26,655,088 | Jun 30, 2024 |
| PICTET ASSET MANAGEMENT HOLDING SA | 1.31% | 0.03% | 1,226,387 | -97,060 | -7.33% | 26,404,112 | Jun 30, 2024 |
| COWEN AND COMPANY, LLC | 1.17% | 0.65% | 1,100,000 | - | - | 23,683,000 | Jun 30, 2024 |
| NOVO HOLDINGS A/S | 1.17% | 1.38% | 1,100,000 | 50,000 | 4.76% | 23,683,000 | Jun 30, 2024 |
| AVIDITY PARTNERS MANAGEMENT LP | 1.17% | 1.01% | 1,100,000 | 75,000 | 7.32% | 23,683,000 | Jun 30, 2024 |
| BAMCO INC /NY/ | 1.04% | 0.06% | 979,331 | -11,213 | -1.13% | 21,084,996 | Jun 30, 2024 |
Rocket Pharmaceuticals's largest institutional shareholder is RTW INVESTMENTS, LP, holding 18.87% of the company's total share outstanding, currently valued at $380.82M. The top 10 institutional shareholders own together 61.70% of the company.
Institutional Shareholders by % of Total Assets
| Name | % Total Shares | % Total Assets | Current Shares | Change Amount | Change % | Market Value | Date |
|---|---|---|---|---|---|---|---|
| M28 CAPITAL MANAGEMENT LP | 0.41% | 10.76% | 385,680 | - | - | 8,303,690 | Jun 30, 2024 |
| RTW INVESTMENTS, LP | 18.87% | 5.90% | 17,687,772 | - | - | 380,817,731 | Jun 30, 2024 |
| ACUTA CAPITAL PARTNERS, LLC | 0.27% | 4.54% | 250,370 | -76,417 | -23.38% | 5,390,466 | Jun 30, 2024 |
| NEW LEAF VENTURE PARTNERS, L.L.C. | 0.16% | 3.95% | 150,706 | 32,464 | 27.46% | 3,244,700 | Jun 30, 2024 |
| FIRST TURN MANAGEMENT, LLC | 0.60% | 1.96% | 560,989 | 310,119 | 123.62% | 12,078,093 | Jun 30, 2024 |
| BOXER CAPITAL, LLC | 1.56% | 1.66% | 1,466,051 | - | - | 31,564,078 | Jun 30, 2024 |
| TANG CAPITAL MANAGEMENT LLC | 0.80% | 1.64% | 750,000 | 90,000 | 13.64% | 16,147,500 | Jun 30, 2024 |
| MAVERICK CAPITAL LTD | 4.19% | 1.60% | 3,928,312 | 40,000 | 1.03% | 84,576,557 | Jun 30, 2024 |
| FRAZIER LIFE SCIENCES MANAGEMENT, L.P. | 1.67% | 1.57% | 1,561,230 | - | - | 33,613,282 | Jun 30, 2024 |
| NOVO HOLDINGS A/S | 1.17% | 1.38% | 1,100,000 | 50,000 | 4.76% | 23,683,000 | Jun 30, 2024 |
| PRIVIUM FUND MANAGEMENT B.V. | 0.27% | 1.27% | 250,980 | 15,930 | 6.78% | 4,964,384 | Jun 30, 2024 |
| AVIDITY PARTNERS MANAGEMENT LP | 1.17% | 1.01% | 1,100,000 | 75,000 | 7.32% | 23,683,000 | Jun 30, 2024 |
| EFG ASSET MANAGEMENT (NORTH AMERICA) CORP. | 0.24% | 0.83% | 222,046 | 71,044 | 47.05% | 4,779,540 | Jun 30, 2024 |
| IKARIAN CAPITAL, LLC | 0.21% | 0.74% | 197,096 | -100,000 | -33.66% | 4,243,477 | Jun 30, 2024 |
| COWEN AND COMPANY, LLC | 1.17% | 0.65% | 1,100,000 | - | - | 23,683,000 | Jun 30, 2024 |
| PERCEPTIVE ADVISORS LLC | 1.33% | 0.64% | 1,246,597 | -554,471 | -30.79% | 26,839,233 | Jun 30, 2024 |
| LOGOS GLOBAL MANAGEMENT LP | 0.37% | 0.61% | 350,000 | -950,000 | -73.08% | 7,535,500 | Jun 30, 2024 |
| SPHERA FUNDS MANAGEMENT LTD. | 0.22% | 0.61% | 206,933 | 23,211 | 12.63% | 4,455,267 | Jun 30, 2024 |
| WESTFIELD CAPITAL MANAGEMENT CO LP | 4.62% | 0.46% | 4,327,922 | 343,892 | 8.63% | 93,180,161 | Jun 30, 2024 |
| ECOR1 CAPITAL, LLC | 0.54% | 0.33% | 508,393 | 508,393 | 100.00% | 10,945,701 | Jun 30, 2024 |
The largest Rocket Pharmaceuticals shareholder by % of total assets is M28 CAPITAL MANAGEMENT LP. The company owns 385.68K shares of Rocket Pharmaceuticals (RCKT), representing 10.76% of its total assets.
Institutional Buyers
| Name | % Total Shares | % Total Assets | Current Shares | Change Amount | Change % | Market Value | Date |
|---|---|---|---|---|---|---|---|
| WOODLINE PARTNERS LP | 0.60% | 0.12% | 561,966 | 561,966 | 100.00% | 12,099,128 | Jun 30, 2024 |
| ECOR1 CAPITAL, LLC | 0.54% | 0.33% | 508,393 | 508,393 | 100.00% | 10,945,701 | Jun 30, 2024 |
| VANGUARD GROUP INC | 6.20% | 0.00% | 5,808,550 | 437,665 | 8.15% | 125,058,083 | Jun 30, 2024 |
| WESTFIELD CAPITAL MANAGEMENT CO LP | 4.62% | 0.46% | 4,327,922 | 343,892 | 8.63% | 93,180,161 | Jun 30, 2024 |
| JANUS HENDERSON GROUP PLC | 3.11% | 0.03% | 2,919,078 | 313,062 | 12.01% | 62,842,455 | Jun 30, 2024 |
| INVESCO LTD. | 0.38% | 0.00% | 352,026 | 310,836 | 754.64% | 7,579,120 | Jun 30, 2024 |
| FIRST TURN MANAGEMENT, LLC | 0.60% | 1.96% | 560,989 | 310,119 | 123.62% | 12,078,093 | Jun 30, 2024 |
| EVENTIDE ASSET MANAGEMENT, LLC | 0.82% | 0.28% | 770,691 | 279,959 | 57.05% | 16,592,977 | Jun 30, 2024 |
| GOLDMAN SACHS GROUP INC | 0.74% | 0.00% | 695,908 | 265,033 | 61.51% | 14,982,890 | Jun 30, 2024 |
| BLACKROCK INC. | 6.61% | 0.00% | 6,192,627 | 262,717 | 4.43% | 133,327,260 | Jun 30, 2024 |
| PRICE T ROWE ASSOCIATES INC /MD/ | 3.38% | 0.01% | 3,169,448 | 226,288 | 7.69% | 68,239,000 | Jun 30, 2024 |
| BANK OF AMERICA CORP /DE/ | 1.32% | 0.00% | 1,238,044 | 219,556 | 21.56% | 26,655,088 | Jun 30, 2024 |
| MIRAE ASSET GLOBAL ETFS HOLDINGS LTD. | 0.21% | 0.01% | 198,771 | 198,771 | 100.00% | 4,279,096 | Jun 30, 2024 |
| COMERICA BANK | 0.73% | 0.06% | 686,654 | 152,129 | 28.46% | 14,783,661 | Jun 30, 2024 |
| SCHRODER INVESTMENT MANAGEMENT GROUP | 0.41% | 0.01% | 386,996 | 111,276 | 40.36% | 8,332,024 | Jun 30, 2024 |
| ALLIANCEBERNSTEIN L.P. | 0.28% | 0.00% | 261,347 | 106,103 | 68.35% | 5,626,801 | Jun 30, 2024 |
| MILLENNIUM MANAGEMENT LLC | 0.11% | 0.00% | 105,325 | 105,325 | 100.00% | 2,267,647 | Jun 30, 2024 |
| GEODE CAPITAL MANAGEMENT, LLC | 1.71% | 0.00% | 1,603,610 | 101,023 | 6.72% | 34,532,870 | Jun 30, 2024 |
| RENAISSANCE TECHNOLOGIES LLC | 0.11% | 0.00% | 99,574 | 99,574 | 100.00% | 2,143,828 | Jun 30, 2024 |
| TANG CAPITAL MANAGEMENT LLC | 0.80% | 1.64% | 750,000 | 90,000 | 13.64% | 16,147,500 | Jun 30, 2024 |
As of Jun 30 2024, Rocket Pharmaceuticals's largest institutional buyer is WOODLINE PARTNERS LP. The company purchased 561.97K stocks of RCKT, valued at $12.10M.
Institutional Sellers
| Name | % Total Shares | % Total Assets | Current Shares | Change Amount | Change % | Market Value | Date |
|---|---|---|---|---|---|---|---|
| STATE STREET CORP | 2.97% | 0.00% | 2,779,866 | -1,413,211 | -33.70% | 59,850,515,000 | Jun 30, 2024 |
| AVORO CAPITAL ADVISORS LLC | - | - | - | -1,260,900 | -100.00% | - | Jun 30, 2024 |
| LOGOS GLOBAL MANAGEMENT LP | 0.37% | 0.61% | 350,000 | -950,000 | -73.08% | 7,535,500 | Jun 30, 2024 |
| PERCEPTIVE ADVISORS LLC | 1.33% | 0.64% | 1,246,597 | -554,471 | -30.79% | 26,839,233 | Jun 30, 2024 |
| CORMORANT ASSET MANAGEMENT, LP | - | - | - | -300,000 | -100.00% | - | Jun 30, 2024 |
| MIRAE ASSET GLOBAL INVESTMENTS CO., LTD. | 0.00% | 0.00% | 2,710 | -299,122 | -99.10% | 58,075 | Jun 30, 2024 |
| MORGAN STANLEY | 0.51% | 0.00% | 475,988 | -212,825 | -30.90% | 10,248,023 | Jun 30, 2024 |
| RAFFERTY ASSET MANAGEMENT, LLC | 0.13% | 0.01% | 117,645 | -211,398 | -64.25% | 2,532,897 | Jun 30, 2024 |
| QUBE RESEARCH & TECHNOLOGIES LTD | - | - | - | -177,524 | -100.00% | - | Jun 30, 2024 |
| CANDRIAM S.C.A. | - | - | - | -165,000 | -100.00% | - | Jun 30, 2024 |
| TWO SIGMA INVESTMENTS, LP | 0.02% | 0.00% | 23,091 | -126,917 | -84.61% | 497,149 | Jun 30, 2024 |
| NICHOLAS INVESTMENT PARTNERS, LP | - | - | - | -119,137 | -100.00% | - | Jun 30, 2024 |
| UBS GROUP AG | 0.43% | 0.00% | 405,782 | -103,172 | -20.27% | 8,736,486 | Jun 30, 2024 |
| JPMORGAN CHASE & CO | 0.62% | 0.00% | 579,738 | -102,786 | -15.06% | 12,481,759 | Jun 30, 2024 |
| SILVERARC CAPITAL MANAGEMENT, LLC | - | - | - | -101,002 | -100.00% | - | Jun 30, 2024 |
| IKARIAN CAPITAL, LLC | 0.21% | 0.74% | 197,096 | -100,000 | -33.66% | 4,243,477 | Jun 30, 2024 |
| PICTET ASSET MANAGEMENT HOLDING SA | 1.31% | 0.03% | 1,226,387 | -97,060 | -7.33% | 26,404,112 | Jun 30, 2024 |
| DIMENSIONAL FUND ADVISORS LP | 1.01% | 0.01% | 946,175 | -83,613 | -8.12% | 20,371,192 | Jun 30, 2024 |
| ACUTA CAPITAL PARTNERS, LLC | 0.27% | 4.54% | 250,370 | -76,417 | -23.38% | 5,390,466 | Jun 30, 2024 |
| PRUDENTIAL FINANCIAL INC | 0.11% | 0.00% | 102,705 | -58,925 | -36.46% | 2,211,239 | Jun 30, 2024 |
As of Jun 30 2024, Rocket Pharmaceuticals's biggest institutional seller is STATE STREET CORP. The company sold -1.41M shares of RCKT, valued at $59.85B.
Institutional New positions
| Name | % Total Shares | % Total Assets | Current Shares | Change Amount | Change % | Market Value | Date |
|---|---|---|---|---|---|---|---|
| WOODLINE PARTNERS LP | 0.60% | 0.12% | 561,966 | 561,966 | 100.00% | 12,099,128 | Jun 30, 2024 |
| ECOR1 CAPITAL, LLC | 0.54% | 0.33% | 508,393 | 508,393 | 100.00% | 10,945,701 | Jun 30, 2024 |
| MIRAE ASSET GLOBAL ETFS HOLDINGS LTD. | 0.21% | 0.01% | 198,771 | 198,771 | 100.00% | 4,279,096 | Jun 30, 2024 |
| COREBRIDGE FINANCIAL, INC. | 0.04% | 0.00% | 35,400 | 35,400 | 100.00% | 762,162 | Jun 30, 2024 |
| NORGES BANK | 0.04% | 0.00% | 34,752 | 34,752 | 100.00% | 748,211 | Jun 30, 2024 |
| STRATEGIC FINANCIAL CONCEPTS, LLC | 0.02% | 0.00% | 21,981 | 21,981 | 100.00% | 895,000 | Jun 30, 2024 |
| MARSHALL WACE, LLP | 0.02% | 0.00% | 19,583 | 19,583 | 100.00% | 421,622 | Jun 30, 2024 |
| CAMPBELL & CO INVESTMENT ADVISER LLC | 0.02% | 0.03% | 17,992 | 17,992 | 100.00% | 387,368 | Jun 30, 2024 |
| GROUP ONE TRADING, L.P. | 0.01% | 0.00% | 6,331 | 6,331 | 100.00% | 136,306,000 | Jun 30, 2024 |
| SIMPLEX TRADING, LLC | 0.01% | 0.00% | 5,825 | 5,825 | 100.00% | 125,000 | Jun 30, 2024 |
| SMARTLEAF ASSET MANAGEMENT LLC | 0.00% | 0.00% | 383 | 383 | 100.00% | 8,207 | Jun 30, 2024 |
| JONES FINANCIAL COMPANIES LLLP | 0.00% | - | 220 | 220 | 100.00% | 4,737 | Jun 30, 2024 |
| BFSG, LLC | 0.00% | 0.00% | 200 | 200 | 100.00% | 4,306 | Jun 30, 2024 |
| MEEDER ASSET MANAGEMENT INC | 0.00% | 0.00% | 178 | 178 | 100.00% | 3,832 | Jun 30, 2024 |
| ADAR1 CAPITAL MANAGEMENT, LLC | 0.00% | 0.00% | 100 | 100 | 100.00% | 2,153 | Jun 30, 2024 |
| INNEALTA CAPITAL, LLC | 0.00% | 0.00% | 49 | 49 | 100.00% | 1,055 | Jun 30, 2024 |
| NATIONAL BANK OF CANADA /FI/ | - | - | 35 | 35 | 100.00% | 720 | Jun 30, 2024 |
| ALLSPRING GLOBAL INVESTMENTS HOLDINGS, LLC | - | - | 20 | 20 | 100.00% | 430 | Jun 30, 2024 |
Rocket Pharmaceuticals's largest new institutional shareholder by number of shares is WOODLINE PARTNERS LP, purchased 561.97K shares, valued at $12.10M, as of undefined.
Institutional Sold Out
| Name | % Total Shares | % Total Assets | Current Shares | Change Amount | Change % | Market Value | Date |
|---|---|---|---|---|---|---|---|
| AVORO CAPITAL ADVISORS LLC | - | - | - | -1,260,900 | -100.00% | - | Jun 30, 2024 |
| CORMORANT ASSET MANAGEMENT, LP | - | - | - | -300,000 | -100.00% | - | Jun 30, 2024 |
| QUBE RESEARCH & TECHNOLOGIES LTD | - | - | - | -177,524 | -100.00% | - | Jun 30, 2024 |
| CANDRIAM S.C.A. | - | - | - | -165,000 | -100.00% | - | Jun 30, 2024 |
| NICHOLAS INVESTMENT PARTNERS, LP | - | - | - | -119,137 | -100.00% | - | Jun 30, 2024 |
| SILVERARC CAPITAL MANAGEMENT, LLC | - | - | - | -101,002 | -100.00% | - | Jun 30, 2024 |
| AMERICAN INTERNATIONAL GROUP, INC. | - | - | - | -30,918 | -100.00% | - | Jun 30, 2024 |
| SQUAREPOINT OPS LLC | - | - | - | -27,229 | -100.00% | - | Jun 30, 2024 |
| BARCLAYS PLC | - | - | - | -27,204 | -100.00% | - | Jun 30, 2024 |
| MILLENNIUM MANAGEMENT LLC | - | - | - | -20,000 | -100.00% | - | Jun 30, 2024 |
| GILDER GAGNON HOWE & CO LLC | - | - | - | -19,270 | -100.00% | - | Jun 30, 2024 |
| SCIENTECH RESEARCH LLC | - | - | - | -15,858 | -100.00% | - | Jun 30, 2024 |
| E FUND MANAGEMENT CO., LTD. | - | - | - | -15,549 | -100.00% | - | Jun 30, 2024 |
| TWINBEECH CAPITAL LP | - | - | - | -14,122 | -100.00% | - | Jun 30, 2024 |
| ENTROPY TECHNOLOGIES, LP | - | - | - | -13,544 | -100.00% | - | Jun 30, 2024 |
| GTS SECURITIES LLC | - | - | - | -12,200 | -100.00% | - | Jun 30, 2024 |
| ATOM INVESTORS LP | - | - | - | -11,472 | -100.00% | - | Jun 30, 2024 |
| LEGATO CAPITAL MANAGEMENT LLC | - | - | - | -11,159 | -100.00% | - | Jun 30, 2024 |
| AQR CAPITAL MANAGEMENT LLC | - | - | - | -10,118 | -100.00% | - | Jun 30, 2024 |
| GUGGENHEIM CAPITAL LLC | - | - | - | -9,985 | -100.00% | - | Jun 30, 2024 |
| XTX TOPCO LTD | - | - | - | -9,507 | -100.00% | - | Jun 30, 2024 |
| COBBLESTONE CAPITAL ADVISORS LLC /NY/ | - | - | - | -9,000 | -100.00% | - | Jun 30, 2024 |
| SG AMERICAS SECURITIES, LLC | - | - | - | -8,765 | -100.00% | - | Jun 30, 2024 |
| HSBC HOLDINGS PLC | - | - | - | -8,048 | -100.00% | - | Jun 30, 2024 |
| WOLVERINE TRADING, LLC | - | - | - | -7,900 | -100.00% | - | Jun 30, 2024 |
| PEARL RIVER CAPITAL, LLC | - | - | - | -7,712 | -100.00% | - | Jun 30, 2024 |
| EFG ASSET MANAGEMENT (AMERICAS) CORP. | - | - | - | -7,500 | -100.00% | - | Jun 30, 2024 |
| J. GOLDMAN & CO LP | - | - | - | -6,800 | -100.00% | - | Jun 30, 2024 |
| QUEST PARTNERS LLC | - | - | - | -6,180 | -100.00% | - | Jun 30, 2024 |
| METROPOLITAN LIFE INSURANCE CO/NY | - | - | - | -3,493 | -100.00% | - | Jun 30, 2024 |
| FERNWOOD INVESTMENT MANAGEMENT, LLC | - | - | - | -1,057 | -100.00% | - | Jun 30, 2024 |
| EVERSOURCE WEALTH ADVISORS, LLC | - | - | - | -80 | -100.00% | - | Jun 30, 2024 |
| MASSMUTUAL TRUST CO FSB/ADV | - | - | - | -25 | -100.00% | - | Jun 30, 2024 |
Rocket Pharmaceuticals's largest sold out institutional shareholder by shares sold is AVORO CAPITAL ADVISORS LLC, sold -1.26M shares, valued at -, as of undefined.
Rocket Pharmaceuticals Mutual Fund Holders
| Name | % Total Assets | Total Shares | Change Amount | Change % | Date |
|---|---|---|---|---|---|
| Forum Real Estate Income Fund | 1.14% | 2,000,000 | - | - | Dec 31, 2023 |
| Tema ETF Trust | 1.02% | 45,440 | 30,400 | 202.13% | Feb 29, 2024 |
| LORD ABBETT DEVELOPING GROWTH FUND, INC. | 0.72% | 668,660 | - | - | Jan 31, 2024 |
| F/M Funds Trust | 0.68% | 1,390,157 | -46,560 | -3.24% | Aug 31, 2023 |
| HSBC FUNDS | 0.66% | 21,440 | - | - | Jan 31, 2024 |
| HARTFORD HLS SERIES FUND II INC | 0.50% | 123,842 | 81,342 | 191.39% | Dec 31, 2023 |
| PUTNAM GLOBAL HEALTH CARE FUND | 0.35% | 580,600 | -217,000 | -27.21% | Feb 29, 2024 |
| JANUS ASPEN SERIES | 0.32% | 13,884,066 | 13,884,066 | - | Dec 31, 2023 |
| Federated Hermes MDT Series | 0.29% | 724,223 | - | - | Jan 31, 2024 |
| T. Rowe Price Health Sciences Fund, Inc. | 0.27% | 911,311 | 56,857 | 6.65% | Mar 31, 2024 |
| TEKLA HEALTHCARE INVESTORS | 0.23% | 199,967 | - | - | Mar 31, 2024 |
| JANUS ASPEN SERIES | 0.22% | 9,639,319 | -323,201 | -3.24% | Dec 31, 2023 |
| T. Rowe Price New Horizons Fund, Inc. | 0.20% | 1,014,464 | 160,448 | 18.79% | Mar 31, 2024 |
| TEKLA LIFE SCIENCES INVESTORS | 0.19% | 89,062 | - | - | Mar 31, 2024 |
| Brown Advisory Funds | 0.18% | 6,878,787 | - | - | Mar 31, 2024 |
| Tributary Funds, Inc. | 0.16% | 818,416 | -11,530 | -1.39% | Dec 31, 2023 |
| JANUS INVESTMENT FUND | 0.15% | 46,680,644 | 46,680,644 | - | Dec 31, 2023 |
| ULTRA SERIES FUND | 0.15% | 266,355 | - | - | Mar 31, 2024 |
| AMERICAN CENTURY VARIABLE PORTFOLIOS INC | 0.14% | 345,837 | 345,837 | - | Mar 31, 2024 |
| AMERICAN CENTURY INVESTMENT TRUST | 0.13% | 18,551,727 | 18,551,727 | - | Mar 31, 2024 |
| SIT MUTUAL FUNDS II INC | 0.13% | 964,485 | -28,297 | -2.85% | Mar 28, 2024 |
| MORGAN STANLEY MORTGAGE SECURITIES TRUST | 0.12% | 731,250 | - | - | Jan 31, 2024 |
| Voya VARIABLE PRODUCTS TRUST | 0.12% | 41,455 | - | - | Mar 31, 2024 |
| JANUS ASPEN SERIES | 0.12% | 5,024,238 | -209,590 | -4.00% | Dec 31, 2023 |
| JANUS INVESTMENT FUND | 0.11% | 33,074,869 | -1,108,982 | -3.24% | Dec 31, 2023 |
| ETFis Series Trust I | 0.10% | 149,296 | -6,531 | -4.19% | Jan 31, 2024 |
| CALVERT VARIABLE SERIES INC | 0.10% | 194,250 | - | - | Mar 31, 2024 |
| BARON INVESTMENT FUNDS TRUST (f/k/a BARON ASSET FUND) | 0.10% | 690,270 | -58,000 | -7.75% | Mar 31, 2024 |
| T. Rowe Price Small-Cap Value Fund, Inc. | 0.10% | 765,247 | - | - | Mar 31, 2024 |
| T. Rowe Price Quantitative Management Funds, Inc. | 0.10% | 308,899 | 22,870 | 8.00% | Mar 31, 2024 |
| BlackRock Health Sciences Trust II | 0.10% | 252,097 | - | - | Mar 31, 2024 |
| Virtus Total Return Fund Inc. | 0.09% | 180,501 | -6,554 | -3.50% | Feb 29, 2024 |
| Janus Detroit Street Trust | 0.09% | 14,074,296 | 4,884,066 | 53.14% | Jan 31, 2024 |
| AMERICAN CENTURY VARIABLE PORTFOLIOS INC | 0.09% | 225,000 | 225,000 | - | Mar 31, 2024 |
| VANGUARD VALLEY FORGE FUNDS | 0.08% | 41,980 | - | - | Mar 31, 2024 |
| AMERICAN CENTURY INVESTMENT TRUST | 0.08% | 11,250,000 | 11,250,000 | - | Mar 31, 2024 |
| JANUS ASPEN SERIES | 0.08% | 3,361,828 | -42,355 | -1.24% | Dec 31, 2023 |
| VANGUARD SPECIALIZED FUNDS | 0.07% | 4,092,055 | - | - | Jan 31, 2024 |
| MADISON FUNDS | 0.07% | 425,246 | -4,749 | -1.10% | Jan 31, 2024 |
| BlackRock Health Sciences Trust | 0.07% | 18,343 | - | - | Mar 31, 2024 |
| STATE STREET INSTITUTIONAL FUNDS | 0.06% | 48,230 | 48,230 | - | Mar 31, 2024 |
| VELA Funds | 0.06% | 19,830 | 4,504 | 29.39% | Dec 31, 2023 |
| JANUS INVESTMENT FUND | 0.06% | 17,557,238 | -732,412 | -4.00% | Dec 31, 2023 |
| LORD ABBETT RESEARCH FUND INC | 0.05% | 49,204 | - | - | Feb 29, 2024 |
| DELAWARE GROUP EQUITY FUNDS IV | 0.05% | 58,000 | - | - | Mar 28, 2024 |
| JANUS INVESTMENT FUND | 0.05% | 14,527,899 | -183,035 | -1.24% | Dec 31, 2023 |
| Voya EQUITY TRUST | 0.05% | 68,548 | - | - | Feb 29, 2024 |
| PRUDENTIAL JENNISON BLEND FUND, INC. | 0.04% | 25,621 | -1,326 | -4.92% | Feb 29, 2024 |
| FRANKLIN STRATEGIC SERIES | 0.04% | 345,346 | 127,820 | 58.76% | Jan 31, 2024 |
| Collaborative Investment Series Trust | 0.04% | 6,027 | - | - | Mar 31, 2024 |
| PRUDENTIAL SERIES FUND | 0.04% | 2,964,324 | 2,964,324 | - | Mar 28, 2024 |
| HARBOR FUNDS | 0.03% | 793,734 | -172,818 | -17.88% | Jan 31, 2024 |
| BlackRock Advantage SMID Cap Fund, Inc. | 0.03% | 6,183 | - | - | Mar 28, 2024 |
| Humankind Benefit Corp | 0.03% | 700 | - | - | Dec 31, 2023 |
| VIRTUS OPPORTUNITIES TRUST | 0.03% | 8,305,386 | -402,638 | -4.62% | Mar 28, 2024 |
| MAINSTAY VP FUNDS TRUST | 0.03% | 3,455,335 | - | - | Mar 31, 2024 |
| VIRTUS EQUITY TRUST | 0.03% | 222,503 | -5,777 | -2.53% | Mar 28, 2024 |
| T. Rowe Price Equity Series, Inc. | 0.03% | 43,255 | 3,567 | 8.99% | Mar 31, 2024 |
| ALLSPRING FUNDS TRUST | 0.03% | 11,826,548 | -510,426 | -4.14% | Feb 29, 2024 |
| VIRTUS OPPORTUNITIES TRUST | 0.03% | 7,061,617 | -349,222 | -4.71% | Mar 28, 2024 |
| BARON SELECT FUNDS | 0.02% | 261,254 | - | - | Mar 31, 2024 |
| MAINSTAY VP FUNDS TRUST | 0.02% | 3,083,000 | 3,083,000 | - | Mar 31, 2024 |
| LORD ABBETT SECURITIES TRUST | 0.02% | 107,713 | - | - | Jan 31, 2024 |
| LORD ABBETT SERIES FUND INC | 0.02% | 1,380,000 | - | - | Mar 31, 2024 |
| QUANTITATIVE MASTER SERIES LLC | 0.02% | 110,583 | -3,274 | -2.88% | Mar 31, 2024 |
| Trust for Advised Portfolios | 0.02% | 363,033 | - | - | Dec 31, 2023 |
| PUTNAM INVESTMENT FUNDS | 0.02% | 88,325 | -33,000 | -27.20% | Jan 31, 2024 |
| PIMCO ETF Trust | 0.02% | 5,000,000 | 5,000,000 | - | Mar 31, 2024 |
| MAINSTAY VP FUNDS TRUST | 0.02% | 2,112,223 | -61,970 | -2.85% | Mar 31, 2024 |
| PIMCO Managed Accounts Trust | 0.02% | 922,820 | -44,737 | -4.62% | Mar 31, 2024 |
| IndexIQ ETF Trust | 0.02% | 36,133 | - | - | Jan 31, 2024 |
| DEUTSCHE DWS INVESTMENTS VIT FUNDS | 0.02% | 9,255 | -300 | -3.14% | Mar 31, 2024 |
| RUSSELL INVESTMENT FUNDS | 0.02% | 1,800,000 | 1,800,000 | - | Mar 31, 2024 |
| GUGGENHEIM FUNDS TRUST | 0.02% | 8,708,024 | -291,975 | -3.24% | Dec 31, 2023 |
| ETFis Series Trust I | 0.01% | 20,955 | - | - | Jan 31, 2024 |
| RBB FUND, INC. | 0.01% | 1,355,628 | -16,025 | -1.17% | Feb 29, 2024 |
| VIRTUS VARIABLE INSURANCE TRUST | 0.01% | 21,000 | - | - | Mar 28, 2024 |
| ALGER FUNDS | 0.01% | 12,495 | - | - | Jan 31, 2024 |
| JANUS INVESTMENT FUND | 0.01% | 3,900,000 | - | - | Dec 31, 2023 |
| VIRTUS OPPORTUNITIES TRUST | 0.01% | 3,530,328 | -91,663 | -2.53% | Mar 28, 2024 |
| CALVERT SOCIAL INVESTMENT FUND | 0.01% | 537,000 | - | - | Mar 31, 2024 |
| RUSSELL INVESTMENT FUNDS | 0.01% | 1,349,755 | 1,349,755 | - | Mar 31, 2024 |
| VANGUARD INDEX FUNDS | 0.01% | 4,485,139 | -1,195,529 | -21.05% | Mar 31, 2024 |
| GUGGENHEIM FUNDS TRUST | 0.01% | 5,786,241 | -462,553 | -7.40% | Dec 31, 2023 |
| AMERICAN CENTURY QUANTITATIVE EQUITY FUNDS, INC. | 0.01% | 22,755 | - | - | Mar 31, 2024 |
| LORD ABBETT INVESTMENT TRUST | 0.01% | 9,225,000 | - | - | Feb 29, 2024 |
| MAINSTAY VP FUNDS TRUST | 0.01% | 1,169,777 | -348,869 | -22.97% | Mar 31, 2024 |
| FORUM FUNDS | 0.01% | 21,170 | - | - | Jan 31, 2024 |
| AdvisorShares Trust | 0.01% | 36,751 | - | - | Mar 28, 2024 |
| FIDELITY COMMONWEALTH TRUST | 0.01% | 28,924 | 465 | 1.63% | Feb 29, 2024 |
| Dunham Funds | 0.01% | 582,671 | -25,167 | -4.14% | Jan 31, 2024 |
| FIDELITY CAPITAL TRUST | 0.01% | 92,900 | - | - | Jan 31, 2024 |
| FIDELITY SELECT PORTFOLIOS | 0.01% | 532,936 | 117,900 | 28.41% | Feb 29, 2024 |
| RUSSELL INVESTMENT FUNDS | 0.01% | 881,293 | -42,724 | -4.62% | Mar 31, 2024 |
| MAINSTAY VP FUNDS TRUST | 0.01% | 945,619 | 945,619 | - | Mar 31, 2024 |
| HARTFORD SERIES FUND INC | 0.01% | 290,083 | 137,812 | 90.50% | Mar 31, 2024 |
| TIAA SEPARATE ACCOUNT VA 1 | 0.01% | 1,412 | - | - | Mar 31, 2024 |
| MAINSTAY VP FUNDS TRUST | 0.01% | 749,846 | -37,082 | -4.71% | Mar 31, 2024 |
| NEUBERGER BERMAN EQUITY FUNDS | 0.01% | 56,906 | 56,906 | - | Feb 29, 2024 |
| Harbor ETF Trust | 0.01% | 24,075 | -3,855 | -13.80% | Jan 31, 2024 |
Rocket Pharmaceuticals's largest mutual fund holder by % of total assets is "Forum Real Estate Income Fund", owning 2.00M shares, compromising 1.14% of its total assets.
Rocket Pharmaceuticals Institutional Ownership Trends
Institutional Holdings Trend
| Date | Holdings | Change % |
|---|---|---|
| 30 Jun, 24 | 75 | -62.12% |
| 31 Mar, 24 | 198 | -4.81% |
| 31 Dec, 23 | 208 | 11.83% |
| 30 Sep, 23 | 186 | 12.73% |
| 30 Jun, 23 | 165 | -0.60% |
| 31 Mar, 23 | 166 | -2.92% |
| 31 Dec, 22 | 171 | 2.40% |
| 30 Sep, 22 | 167 | 13.61% |
| 30 Jun, 22 | 147 | 0.68% |
| 31 Mar, 22 | 146 | 1.39% |
| 31 Dec, 21 | 144 | -4.64% |
| 30 Sep, 21 | 151 | -3.82% |
| 30 Jun, 21 | 157 | -12.78% |
| 31 Mar, 21 | 180 | -1.64% |
| 31 Dec, 20 | 183 | 42.97% |
| 30 Sep, 20 | 128 | 6.67% |
| 30 Jun, 20 | 120 | 10.09% |
| 31 Mar, 20 | 109 | -12.10% |
| 31 Dec, 19 | 124 | 29.17% |
| 30 Sep, 19 | 96 | -4.00% |
| 30 Jun, 19 | 100 | 17.65% |
| 31 Mar, 19 | 85 | -4.49% |
| 31 Dec, 18 | 89 | 4.71% |
| 30 Sep, 18 | 85 | 10.39% |
| 30 Jun, 18 | 77 | 32.76% |
| 31 Mar, 18 | 58 | - |
As of 30 Jun 24, 75 institutions are holding Rocket Pharmaceuticals's shares, representing a decrease of -62.12% compared to the previous quarter.
Shares Outstanding Trend
| Date | Shares Outstanding | Change % |
|---|---|---|
| 30 Jun, 24 | 8,411,828 | -90.88% |
| 31 Mar, 24 | 92,260,410 | 3.68% |
| 31 Dec, 23 | 88,988,481 | -0.19% |
| 30 Sep, 23 | 89,160,691 | 17.17% |
| 30 Jun, 23 | 76,094,163 | -2.75% |
| 31 Mar, 23 | 78,247,577 | -96.47% |
| 31 Dec, 22 | 2,218,776,379 | 3112.78% |
| 30 Sep, 22 | 69,060,973 | 6.61% |
| 30 Jun, 22 | 64,778,238 | 0.64% |
| 31 Mar, 22 | 64,368,450 | 1.82% |
| 31 Dec, 21 | 63,217,518 | 1.57% |
| 30 Sep, 21 | 62,239,845 | 0.51% |
| 30 Jun, 21 | 61,922,829 | -0.10% |
| 31 Mar, 21 | 61,986,338 | -0.28% |
| 31 Dec, 20 | 62,160,134 | 12.50% |
| 30 Sep, 20 | 55,254,833 | 1.86% |
| 30 Jun, 20 | 54,248,515 | 1.71% |
| 31 Mar, 20 | 53,335,626 | 3.18% |
| 31 Dec, 19 | 51,691,392 | 8.37% |
| 30 Sep, 19 | 47,699,948 | -2.80% |
| 30 Jun, 19 | 49,076,393 | 14.46% |
| 31 Mar, 19 | 42,874,653 | 1.83% |
| 31 Dec, 18 | 42,105,468 | 14.44% |
| 30 Sep, 18 | 36,794,028 | 8.12% |
| 30 Jun, 18 | 34,030,020 | 9.98% |
| 31 Mar, 18 | 30,941,557 | - |
Rocket Pharmaceuticals (RCKT) has 8.41M shares outstanding as of 30 Jun 24, down -90.88% compared to the previous quarter.
Institutional Ownership Trend
| Date | Ownership % | Change % |
|---|---|---|
| 30 Jun, 24 | 8.97% | 0.09% |
| 31 Mar, 24 | 98.62% | 1.08% |
| 31 Dec, 23 | 95.34% | 0.82% |
| 30 Sep, 23 | 107.90% | 1.21% |
| 30 Jun, 23 | 94.56% | 0.97% |
| 31 Mar, 23 | 98.48% | 0.00% |
| 31 Dec, 22 | 3044.03% | 27.98% |
| 30 Sep, 22 | 104.30% | 1.07% |
| 30 Jun, 22 | 98.93% | 0.99% |
| 31 Mar, 22 | 99.78% | 1.00% |
| 31 Dec, 21 | 99.97% | 1.05% |
| 30 Sep, 21 | 97.52% | 1.01% |
| 30 Jun, 21 | 98.19% | 0.97% |
| 31 Mar, 21 | 100.67% | 0.79% |
| 31 Dec, 20 | 112.63% | 1.12% |
| 30 Sep, 20 | 100.12% | 1.04% |
| 30 Jun, 20 | 98.35% | 1.04% |
| 31 Mar, 20 | 97.18% | 0.87% |
| 31 Dec, 19 | 105.47% | 1.18% |
| 30 Sep, 19 | 94.71% | 0.95% |
| 30 Jun, 19 | 99.61% | 1.10% |
| 31 Mar, 19 | 95.02% | 1.09% |
| 31 Dec, 18 | 93.31% | 1.10% |
| 30 Sep, 18 | 92.21% | 1.24% |
| 30 Jun, 18 | 86.19% | 1.18% |
| 31 Mar, 18 | 85.62% | - |
As of 30 Jun 24, Rocket Pharmaceuticals is held by 8.97% institutional shareholders, representing a 0.09% growth compared to 31 Mar 24.
Institutional Increased Positions Trend
| Date | Increased Positions | Change % |
|---|---|---|
| 30 Jun, 24 | 38 | -56.82% |
| 31 Mar, 24 | 88 | -16.19% |
| 31 Dec, 23 | 105 | -5.41% |
| 30 Sep, 23 | 111 | 37.04% |
| 30 Jun, 23 | 81 | 6.58% |
| 31 Mar, 23 | 76 | -37.70% |
| 31 Dec, 22 | 122 | 29.79% |
| 30 Sep, 22 | 94 | 13.25% |
| 30 Jun, 22 | 83 | 3.75% |
| 31 Mar, 22 | 80 | -2.44% |
| 31 Dec, 21 | 82 | 26.15% |
| 30 Sep, 21 | 65 | -15.58% |
| 30 Jun, 21 | 77 | -23.76% |
| 31 Mar, 21 | 101 | -7.34% |
| 31 Dec, 20 | 109 | 78.69% |
| 30 Sep, 20 | 61 | -19.74% |
| 30 Jun, 20 | 76 | 38.18% |
| 31 Mar, 20 | 55 | -29.49% |
| 31 Dec, 19 | 78 | 44.44% |
| 30 Sep, 19 | 54 | -22.86% |
| 30 Jun, 19 | 70 | 62.79% |
| 31 Mar, 19 | 43 | -20.37% |
| 31 Dec, 18 | 54 | 28.57% |
| 30 Sep, 18 | 42 | -20.75% |
| 30 Jun, 18 | 53 | -7.02% |
| 31 Mar, 18 | 57 | - |
38 institutional shareholders have increased their position in RCKT stock as of 30 Jun 24 compared to 88 in the previous quarter (a -56.82% decrease).
Institutional Reduced Positions Trend
| Date | Reduced Positions | Change % |
|---|---|---|
| 30 Jun, 24 | 18 | -72.31% |
| 31 Mar, 24 | 65 | -5.80% |
| 31 Dec, 23 | 69 | 56.82% |
| 30 Sep, 23 | 44 | -15.38% |
| 30 Jun, 23 | 52 | -11.86% |
| 31 Mar, 23 | 59 | 78.79% |
| 31 Dec, 22 | 33 | -19.51% |
| 30 Sep, 22 | 41 | 2.50% |
| 30 Jun, 22 | 40 | -6.98% |
| 31 Mar, 22 | 43 | - |
| 31 Dec, 21 | 43 | -12.24% |
| 30 Sep, 21 | 49 | -3.92% |
| 30 Jun, 21 | 51 | -1.92% |
| 31 Mar, 21 | 52 | 1.96% |
| 31 Dec, 20 | 51 | 13.33% |
| 30 Sep, 20 | 45 | 87.50% |
| 30 Jun, 20 | 24 | -20.00% |
| 31 Mar, 20 | 30 | 7.14% |
| 31 Dec, 19 | 28 | 47.37% |
| 30 Sep, 19 | 19 | 11.76% |
| 30 Jun, 19 | 17 | -5.56% |
| 31 Mar, 19 | 18 | 38.46% |
| 31 Dec, 18 | 13 | -38.10% |
| 30 Sep, 18 | 21 | 40.00% |
| 30 Jun, 18 | 15 | - |
| 31 Mar, 18 | - | - |
18 institutional shareholders have reduced their position in RCKT stock as of 30 Jun 24 compared to 65 in the previous quarter (a -72.31% decrease).
All Institutional Ownership Trend Data
| Date | Holdings | Change % | Shares Outstanding | Change % | Ownership % | Change % | Increased Positions | Change % | Reduced Positions | Change % |
|---|---|---|---|---|---|---|---|---|---|---|
| 30 Jun, 24 | 75 | -62.12% | 8,411,828 | -90.88% | 8.97% | 0.09% | 38 | -56.82% | 18 | -72.31% |
| 31 Mar, 24 | 198 | -4.81% | 92,260,410 | 3.68% | 98.62% | 1.08% | 88 | -16.19% | 65 | -5.80% |
| 31 Dec, 23 | 208 | 11.83% | 88,988,481 | -0.19% | 95.34% | 0.82% | 105 | -5.41% | 69 | 56.82% |
| 30 Sep, 23 | 186 | 12.73% | 89,160,691 | 17.17% | 107.90% | 1.21% | 111 | 37.04% | 44 | -15.38% |
| 30 Jun, 23 | 165 | -0.60% | 76,094,163 | -2.75% | 94.56% | 0.97% | 81 | 6.58% | 52 | -11.86% |
| 31 Mar, 23 | 166 | -2.92% | 78,247,577 | -96.47% | 98.48% | 0.00% | 76 | -37.70% | 59 | 78.79% |
| 31 Dec, 22 | 171 | 2.40% | 2,218,776,379 | 3112.78% | 3044.03% | 27.98% | 122 | 29.79% | 33 | -19.51% |
| 30 Sep, 22 | 167 | 13.61% | 69,060,973 | 6.61% | 104.30% | 1.07% | 94 | 13.25% | 41 | 2.50% |
| 30 Jun, 22 | 147 | 0.68% | 64,778,238 | 0.64% | 98.93% | 0.99% | 83 | 3.75% | 40 | -6.98% |
| 31 Mar, 22 | 146 | 1.39% | 64,368,450 | 1.82% | 99.78% | 1.00% | 80 | -2.44% | 43 | - |
| 31 Dec, 21 | 144 | -4.64% | 63,217,518 | 1.57% | 99.97% | 1.05% | 82 | 26.15% | 43 | -12.24% |
| 30 Sep, 21 | 151 | -3.82% | 62,239,845 | 0.51% | 97.52% | 1.01% | 65 | -15.58% | 49 | -3.92% |
| 30 Jun, 21 | 157 | -12.78% | 61,922,829 | -0.10% | 98.19% | 0.97% | 77 | -23.76% | 51 | -1.92% |
| 31 Mar, 21 | 180 | -1.64% | 61,986,338 | -0.28% | 100.67% | 0.79% | 101 | -7.34% | 52 | 1.96% |
| 31 Dec, 20 | 183 | 42.97% | 62,160,134 | 12.50% | 112.63% | 1.12% | 109 | 78.69% | 51 | 13.33% |
| 30 Sep, 20 | 128 | 6.67% | 55,254,833 | 1.86% | 100.12% | 1.04% | 61 | -19.74% | 45 | 87.50% |
| 30 Jun, 20 | 120 | 10.09% | 54,248,515 | 1.71% | 98.35% | 1.04% | 76 | 38.18% | 24 | -20.00% |
| 31 Mar, 20 | 109 | -12.10% | 53,335,626 | 3.18% | 97.18% | 0.87% | 55 | -29.49% | 30 | 7.14% |
| 31 Dec, 19 | 124 | 29.17% | 51,691,392 | 8.37% | 105.47% | 1.18% | 78 | 44.44% | 28 | 47.37% |
| 30 Sep, 19 | 96 | -4.00% | 47,699,948 | -2.80% | 94.71% | 0.95% | 54 | -22.86% | 19 | 11.76% |
| 30 Jun, 19 | 100 | 17.65% | 49,076,393 | 14.46% | 99.61% | 1.10% | 70 | 62.79% | 17 | -5.56% |
| 31 Mar, 19 | 85 | -4.49% | 42,874,653 | 1.83% | 95.02% | 1.09% | 43 | -20.37% | 18 | 38.46% |
| 31 Dec, 18 | 89 | 4.71% | 42,105,468 | 14.44% | 93.31% | 1.10% | 54 | 28.57% | 13 | -38.10% |
| 30 Sep, 18 | 85 | 10.39% | 36,794,028 | 8.12% | 92.21% | 1.24% | 42 | -20.75% | 21 | 40.00% |
| 30 Jun, 18 | 77 | 32.76% | 34,030,020 | 9.98% | 86.19% | 1.18% | 53 | -7.02% | 15 | - |
| 31 Mar, 18 | 58 | - | 30,941,557 | - | 85.62% | - | 57 | - | - | - |
Rocket Pharmaceuticals Insider Shareholders Trades
Open Market Insider Trades
Open Market Insider Buys
| Date | Name | Relation | Role | Transaction | Buy/Sell | Shares | Price | Value | Shares Held | Source |
|---|
Insider Sells
All Insider Owners Trades
The last insider sell of Rocket Pharmaceuticals's stock was made by Militello John on Jul 24 2024, selling 812 shares at $23.02 per share (valued at $18.69K).
Rocket Pharmaceuticals Insider Ownership Trends
All Insider Trades Trend
| Date | Buy | Sell | Buy/Sell Ratio |
|---|---|---|---|
| Q1 2025 | - | 1 | - |
| Q3 2024 | - | 2 | - |
| Q2 2024 | 22 | 18 | 122.22% |
| Q1 2024 | 14 | 22 | 63.64% |
| Q4 2023 | 6 | 8 | 75.00% |
| Q3 2023 | 7 | 14 | 50.00% |
| Q2 2023 | 19 | 7 | 271.43% |
| Q1 2023 | 31 | 8 | 387.50% |
| Q4 2022 | 6 | - | - |
| Q3 2022 | 7 | - | - |
| Q2 2022 | 19 | 2 | 950.00% |
| Q1 2022 | 15 | 6 | 250.00% |
| Q4 2021 | 1 | - | - |
| Q3 2021 | 2 | 1 | 200.00% |
| Q2 2021 | 11 | 6 | 183.33% |
| Q1 2021 | 10 | 15 | 66.67% |
| Q4 2020 | 5 | 5 | 100.00% |
| Q3 2020 | 2 | 1 | 200.00% |
| Q2 2020 | 10 | - | - |
| Q1 2020 | 12 | 6 | 200.00% |
0 total buy trades, and 1 total sell trades (buy/sell ratio of 0.00%) were made by Rocket Pharmaceuticals's insiders, as of Q1 2025.
Open Market Insider Trades Trend
| Date | Buy | Sell | Buy/Sell Ratio |
|---|---|---|---|
| Q1 2025 | - | - | - |
| Q3 2024 | - | 2 | - |
| Q2 2024 | - | 9 | - |
| Q1 2024 | - | 9 | - |
| Q4 2023 | - | 2 | - |
| Q3 2023 | 1 | 6 | 16.67% |
| Q2 2023 | - | 4 | - |
| Q1 2023 | - | 4 | - |
| Q4 2022 | 2 | - | - |
| Q3 2022 | - | - | - |
| Q2 2022 | - | 2 | - |
| Q1 2022 | 1 | 5 | 20.00% |
| Q4 2021 | - | - | - |
| Q3 2021 | - | - | - |
| Q2 2021 | - | 3 | - |
| Q1 2021 | - | - | - |
| Q4 2020 | 1 | 2 | 50.00% |
| Q3 2020 | - | - | - |
| Q2 2020 | - | - | - |
| Q1 2020 | 1 | - | - |
As of Q1 2025, Insider owners conducted 0 open market buy trades and 0 open market sell trades of Rocket Pharmaceuticals's stocks.
Rocket Pharmaceuticals Peer Ownership
| Ticker | Company |
|---|---|
| PLRX | Pliant Therapeutics, Inc. |
| DYN | Dyne Therapeutics, Inc. |
| RVMD | Revolution Medicines, Inc. Warrant |
| VRDN | Viridian Therapeutics, Inc. |
| MRUS | Merus N.V. |
| LRMR | Larimar Therapeutics, Inc. |
| DAWN | Day One Biopharmaceuticals, Inc. |
| MGTX | MeiraGTx Holdings plc |
| STOK | Stoke Therapeutics, Inc. |
| STRO | Sutro Biopharma, Inc. |
| RGNX | REGENXBIO Inc. |
| REPL | Replimune Group, Inc. |
| SNDX | Syndax Pharmaceuticals, Inc. |
| INZY | Inozyme Pharma, Inc. |
| RYTM | Rhythm Pharmaceuticals, Inc. |
| PCVX | Vaxcyte, Inc. |
| SLDB | Solid Biosciences Inc. |
| CYTK | Cytokinetics, Incorporated |
| QURE | uniQure N.V. |
| MIRM | Mirum Pharmaceuticals, Inc. |
RCKT Ownership FAQ
Who Owns Rocket Pharmaceuticals?
Rocket Pharmaceuticals is owned by institutional shareholders (8.97%), insiders (3.42%), and public (87.61%). The largest institutional shareholder of Rocket Pharmaceuticals is RTW INVESTMENTS, LP (18.87% of total shares) and the top mutual fund owner is Forum Real Estate Income Fund (1.14% of total shares).
Who are the major institutional shareholders of Rocket Pharmaceuticals?
Rocket Pharmaceuticals's major institutional shareholders are RTW INVESTMENTS, LP, WELLINGTON MANAGEMENT GROUP LLP, BLACKROCK INC., VANGUARD GROUP INC, and WESTFIELD CAPITAL MANAGEMENT CO LP. The top five shareholders own together 46.05% of the company's share outstanding.
How many Rocket Pharmaceuticals shareholders are there?
As of Jun 2024, there are 75 institutional shareholders of Rocket Pharmaceuticals.
What percentage of Rocket Pharmaceuticals is owned by RTW INVESTMENTS, LP?
RTW INVESTMENTS, LP owns 17.69M shares of Rocket Pharmaceuticals, representing 18.87% of the company's total shares outstanding, valued at $380.82M (as of Jun 2024).
What percentage of Rocket Pharmaceuticals is owned by WELLINGTON MANAGEMENT GROUP LLP?
As of Jun 2024, WELLINGTON MANAGEMENT GROUP LLP holds 9.16M shares of Rocket Pharmaceuticals (RCKT), compromising 9.77% of the company, valued at $197.12M.
What percentage of Rocket Pharmaceuticals is owned by BLACKROCK INC?
BLACKROCK INC is the third largest holder of Rocket Pharmaceuticals. The company owns 6.19M of the company's shares outstanding (worth $133.33M).